Rationality Analysis of Drug Use of Pregnant Women in the Outpatient Department of Our Hospita
- VernacularTitle:我院妊娠期妇女门诊用药的合理性分析
- Author:
Xiaowei MA
1
,
2
,
3
;
Hongyan GU
1
,
2
,
3
;
Fang LI
1
,
2
,
3
;
Jinghui TU
4
Author Information
1. Dept. of Pharmacy，Beijing Shijitan Hospital Affiliated to Capital Medical University，Beijing 100038，China
2. Beijing Key Lab of Clinical Rational Drug Use Evaluation，Beijing 100038，China
3. International Cooperative Joint Laboratory for Clinical Rational Drug Use Evaluation，Beijing 100038，China
4. Dept. of Obstetrics，Beijing Shijitan Hospital Affiliated to Capital Medical University，Beijing 100038，China
- Publication Type:Journal Article
- Keywords:
Pregnancy;
Outpatient;
DDDs;
Safety grading;
Pharmacist value
- From:
China Pharmacy
2021;32(9):1114-1117
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE：To invest igtae the rationality of drug use of pregnant women in the outpatient department of our hospital，and to promote rational drug use in the clinic. METHODS ：The prescriptions of pregnant women in Beijing Shijitan Hospital Affiliated to Capital Medical University from Jan. to Dec. in 2019 were extracted by using hospital information management system ，and then analyzed statistically in respects of drug varieties ，DDDs，safety grading ，and use of Chinese patent medicine. RESULTS ：The most frequently used drugs in obstetric outpatients were vitamins and microelements ，followed by blood system and hormone drugs. Grade B drugs with good safety were most used ，the use of ungraded drugs were reasonable ，and grade X drugs were not used. There were 6 kinds of Chinese patent medicines used for pregnant women ，of which 2 kinds were marked “usable”in the drug instructions ，4 kinds were not marked in the dug instructions ，and the Chinese patent medicines that were not marked“prohibited”and“cautious”in the drug instructions were not used. CONCLUSIONS ：The drug use of pregnant women are generally reasonable in outpatient department of our hospital. The safety of some Chinese patent medicine used during pregnancy still needs to be further confirmed.
